Atos SE
Atos SE (AEXAF) Financial Performance & Income Statement Overview
Review Atos SE (AEXAF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Atos SE (AEXAF) Income Statement & Financial Overview
Review Atos SE AEXAF income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $4.61B | $4.96B | $5.14B | $5.55B |
Cost of Revenue | $122.00M | $4.84B | $4.25B | $4.66B |
Gross Profit | $4.49B | $120.00M | $899.00M | $888.00M |
Gross Profit Ratio | $0.97 | $0.02 | $0.17 | $0.16 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $9.00M | $7.00M | $706.00M | $752.00M |
Operating Expenses | $5.45B | $755.00M | $693.00M | $748.00M |
Total Costs & Expenses | $5.57B | $4.88B | $4.94B | $5.41B |
Interest Income | $0.00 | $0.00 | $103.00M | $84.00M |
Interest Expense | $0.00 | $175.00M | $179.00M | $136.00M |
Depreciation & Amortization | $157.00M | $292.00M | $342.00M | $353.00M |
EBITDA | -$2.54B | -$1.40B | $548.00M | $493.00M |
EBITDA Ratio | -$0.55 | -$0.28 | $0.11 | $0.09 |
Operating Income | -$955.00M | $40.00M | $206.00M | $140.00M |
Operating Income Ratio | -$0.21 | $0.008 | $0.04 | $0.03 |
Other Income/Expenses (Net) | $3.30B | -$1.92B | -$3.00B | -$675.00M |
Income Before Tax | $2.34B | -$1.88B | -$2.79B | -$537.00M |
Income Before Tax Ratio | $0.51 | -$0.38 | -$0.54 | -$0.10 |
Income Tax Expense | $152.00M | $62.00M | $47.00M | $65.00M |
Net Income | $2.19B | -$1.94B | -$2.84B | -$600.00M |
Net Income Ratio | $0.47 | -$0.39 | -$0.55 | -$0.11 |
EPS | $138281.74 | -$174754.00 | -$25.60 | -$5.43 |
Diluted EPS | $138369.15 | -$174800.00 | -$25.60 | -$5.43 |
Weighted Avg Shares Outstanding | $15830.00 | $11104.00 | $110.93M | $110.53M |
Weighted Avg Shares Outstanding (Diluted) | $15820.00 | $11107.00 | $110.93M | $110.53M |
Financial performance has remained strong, with revenue growing from $5.55B in Q2 2023 to $4.61B in Q4 2024. Gross profit continued to perform well, with margins at 97% in the latest quarter. Operating income reached -$955.00M in Q4 2024, holding a steady -21% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$2.54B. Net income rose to $2.19B, keeping EPS at $138281.74. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan